Discover Precision Medicine at Functional Longevity Summit Dallas 2026

Dallas, Texas--(Newsfile Corp. - April 22, 2026) - The Functional Longevity Summit Dallas 2026, hosted by Boston BioLife, will take place May 15-17, 2026 at the Hilton Anatole, convening physicians, clinicians, and healthcare innovators at the intersection of precision medicine, regenerative therapies, and practice optimization.

To view the full announcement, including downloadable images, bios, and more, click here.

Key Takeaways:

• Boston BioLife hosts the Functional Longevity Summit Dallas 2026 on May 15-17, 2026 at the Hilton Anatole, convening physicians, clinicians, and healthcare innovators at the intersection of precision medicine, regenerative therapies, and practice optimization.
• The three-day medical education event introduces a new model for medical conferences by providing a clinical and operational training environment centered on practical implementation, revenue and profit optimization, and the integration of multiple modalities into cohesive treatment systems.
• The curriculum covers advanced diagnostics, personalized therapies, regenerative medicine, energy-based modalities, and practice integration, aiming to equip providers with actionable strategies that improve patient outcomes and business performance while closing the gap between technology exposure and sustainable adoption.

Click image above to view full announcement.

About the Functional Longevity Summit

The Functional Longevity Summit is a practitioner-focused educational platform advancing precision, functional, and regenerative medicine through immersive, hands-on training. By combining clinical education with real-world implementation and business strategy, the summit is designed to help providers translate innovation into measurable patient outcomes and scalable practice growth.

Source: Newsworthy.ai

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/293805

You May Also Be Interested In

• Buffalo Potash Announces Closing of C$14.01 Million First Tranche of Oversubscribed and Upsized C$14.85 Million Non-Brokered Private Placement
• Wesdome Extends Reserve Life to 8 Years at Both Mines, Establishes Robust Free Cash Flow Profile, and Outlines Significant Organic Growth Pipeline
• Zodiac Gold closes C$5.6M private placement one day late